Description

Carbamic Acid, [3-[(4-Bromophenyl)Methyl]-2-Butyl-5-Methyl-3H-Imidazo[4,5-B]Pyridin-6-Yl]-, 1,1-Dimethylethyl Ester (9Ci) CAS NO 601502-86-7 is a sophisticated, high-purity organic compound featuring a complex imidazopyridine core structure. This molecule is of significant interest in advanced pharmaceutical research and development, particularly as a key synthetic intermediate or a potential pharmacologically active scaffold. It is primarily utilized by R&D chemists and process development scientists in the life sciences sector. The compound's specific bromophenyl and tert-butyl carbamate functionalities make it a valuable building block for constructing novel chemical entities.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, oncology, or inflammatory diseases.
• Medicinal Chemistry Research: Used as a core scaffold or a derivatization starting point for structure-activity relationship (SAR) studies and high-throughput screening libraries.
• Biochemical Tool Compound: Potential use in developing probes for studying enzyme inhibition or receptor binding assays due to its heterocyclic structure.
• Process Chemistry Development: Employed in optimizing scalable synthetic routes for the production of active pharmaceutical ingredients (APIs) under cGMP conditions.
• Academic Research: Utilized in university and institutional labs for fundamental studies in organic synthesis methodology and heterocyclic chemistry.

Basic Information

Product Name	Carbamic Acid, [3-[(4-Bromophenyl)Methyl]-2-Butyl-5-Methyl-3H-Imidazo[4,5-B]Pyridin-6-Yl]-, 1,1-Dimethylethyl Ester (9Ci)
CAS No.	601502-86-7
Molecular Formula	C23H27BrN4O2
Molecular Weight	471.39 g/mol
Synonyms	tert-Butyl N-[3-[(4-bromophenyl)methyl]-2-butyl-5-methylimidazo[4,5-b]pyridin-6-yl]carbamate; 2-Butyl-3-[(4-bromobenzyl)]-5-methyl-6-[(tert-butoxycarbonyl)amino]imidazo[4,5-b]pyridine; 601502-86-7; (9CI) Carbamic acid, [3-[(4-bromophenyl)methyl]-2-butyl-5-methyl-3H-imidazo[4,5-b]pyridin-6-yl]-, 1,1-dimethylethyl ester; Imidazo[4,5-b]pyridine carbamate derivative
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to rigorous quality standards to ensure batch-to-batch consistency and purity suitable for research and development. Each lot is fully characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profile is provided with every shipment. We support development under quality systems aligned with ISO 9001 and can provide material suitable for use in cGMP-regulated environments upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a cool, dry, and well-ventilated place. The compound may be light-sensitive and/or hygroscopic; prolonged exposure to light, moisture, or extreme temperatures should be avoided to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.